• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[静脉注射后脂质体包裹药物模型物质的消除因素]

[Factors of elimination of liposome-encapsulated drug model substances after intravenous administration].

作者信息

Kibat P, Stricker H

机构信息

Institut für Pharmazeutische Technologie und Biopharmazie, Universität Heidelberg.

出版信息

Arzneimittelforschung. 1988 Oct;38(10):1472-8.

PMID:3196388
Abstract

Carboxyfluorescein (CF) and fluorescein dilaurate (FDL) have been encapsulated in either small or large multilamellar liposomes of various lipid composition. Cholesterol (CH)-free liposomes showed relatively rapid CF release when dispersed in buffer, plasma or whole blood. The same behaviour was seen with liposomes which contained a lipid whose phase transition temperature was less than 37 degrees C. The CH-free preparations also showed marked aggregation in plasma. After i.v. application to rabbits the elimination of liposomal CF was found to depend upon the typ of phospholipid present, the CH content, the surface charge and vesicle size. The lipophilic substance FDL was lost from circulation more rapidly than the hydrophilic CF. All of the measured plasma levels indicated an open two-compartment model, i.e. with two exits. The calculated microconstants provide information about the distribution kinetics.

摘要

羧基荧光素(CF)和二月桂酸荧光素(FDL)已被包封于具有不同脂质组成的小或大多层脂质体中。不含胆固醇(CH)的脂质体分散在缓冲液、血浆或全血中时显示出相对较快的CF释放。含有相变温度低于37℃脂质的脂质体也观察到相同的行为。不含CH的制剂在血浆中也显示出明显的聚集。静脉注射给兔子后,发现脂质体CF的消除取决于所存在的磷脂类型、CH含量、表面电荷和囊泡大小。亲脂性物质FDL从循环中消失的速度比亲水性CF更快。所有测得的血浆水平均表明为开放二室模型,即有两个出口。计算出的微常数提供了有关分布动力学的信息。

相似文献

1
[Factors of elimination of liposome-encapsulated drug model substances after intravenous administration].[静脉注射后脂质体包裹药物模型物质的消除因素]
Arzneimittelforschung. 1988 Oct;38(10):1472-8.
2
Distribution of liposome-incorporated carboxyfluorescein in rabbit eyes.包裹羧基荧光素的脂质体在兔眼中的分布。
J Microencapsul. 1991 Jul-Sep;8(3):391-9. doi: 10.3109/02652049109069566.
3
Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery.肝动脉注射温敏脂质体阿霉素对大鼠W256肝肉瘤的治疗作用增强。
Cancer Res. 1993 Jul 1;53(13):3046-51.
4
Polysulfone capillary fiber for intraocular drug delivery: in vitro and in vivo evaluations.用于眼内药物递送的聚砜毛细管纤维:体外和体内评估
J Drug Target. 1994;2(4):289-98. doi: 10.3109/10611869409015909.
5
Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits.兔肌肉注射脂质体包封的恩诺沙星后的缓释效果。
Am J Vet Res. 1995 Nov;56(11):1498-501.
6
Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma.羧基荧光素在人血浆中从十六烷基甘露糖苷修饰脂质体的尺寸依赖性释放。
Biopharm Drug Dispos. 1996 Mar;17(2):145-54. doi: 10.1002/(SICI)1099-081X(199603)17:2<145::AID-BDD942>3.0.CO;2-Y.
7
Biopharmaceutical evaluation of the liposomes prepared by rehydration of freeze-dried empty liposomes (FDELs) with an aqueous solution of a drug.通过用药物水溶液复水冻干空脂质体(FDELs)制备的脂质体的生物制药评价。
Biopharm Drug Dispos. 1996 Oct;17(7):589-605. doi: 10.1002/(SICI)1099-081X(199610)17:7<589::AID-BDD976>3.0.CO;2-D.
8
Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes.脂质分离和溶血磷脂解离对热敏脂质体药物释放的影响。
J Control Release. 2005 Sep 20;107(1):131-42. doi: 10.1016/j.jconrel.2005.06.001.
9
Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations.可雾化脂质体制剂的药物释放与肺部药物吸收特征的相关性。
Eur J Pharm Biopharm. 2013 May;84(1):106-14. doi: 10.1016/j.ejpb.2012.12.003. Epub 2012 Dec 20.
10
Stability in biological fluids and clearance of immunoliposomes.免疫脂质体在生物流体中的稳定性及清除率
Arzneimittelforschung. 1989 Mar;39(3):415-20.

引用本文的文献

1
Review of operative considerations in spinal cord stem cell therapy.脊髓干细胞治疗的手术考量综述
World J Stem Cells. 2021 Feb 26;13(2):168-176. doi: 10.4252/wjsc.v13.i2.168.
2
Tumour targeting with antibody-coupled liposomes: failure to achieve accumulation in xenografts and spontaneous liver metastases.抗体偶联脂质体的肿瘤靶向性:在异种移植瘤和自发性肝转移灶中未能实现积聚。
Cancer Immunol Immunother. 1990;31(5):285-91. doi: 10.1007/BF01740936.